Kamu erişimi zorunlu olan makaleler - Richard D BoyceDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 2
Transforming the medication regimen review process using telemedicine to prevent adverse events
SL Kane‐Gill, A Wong, CM Culley, S Perera, MD Reynolds, SM Handler, ...
Journal of the American Geriatrics Society 69 (2), 530-538, 2021
Zorunlu olanlar: US National Institutes of Health
Physician Perceptions of Consultant Pharmacist Services Associated with an Intervention for Adverse Drug Events in the Nursing Facility
SL Kane-Gill, JT Hanlon, MJ Fine, S Perera, CM Culley, SA Studenski, ...
The Consultant Pharmacist® 31 (12), 708-720, 2016
Zorunlu olanlar: US National Institutes of Health
Bir yerde sunuluyor: 74
Toward a complete dataset of drug–drug interaction information from publicly available sources
S Ayvaz, J Horn, O Hassanzadeh, Q Zhu, J Stan, NP Tatonetti, S Vilar, ...
Journal of biomedical informatics 55, 206-217, 2015
Zorunlu olanlar: US Department of Energy, US National Institutes of Health, Austrian Science Fund
Consensus recommendations for systematic evaluation of drug–drug interaction evidence for clinical decision support
RT Scheife, LE Hines, RD Boyce, SP Chung, JD Momper, CD Sommer, ...
Drug safety 38, 197-206, 2015
Zorunlu olanlar: US National Institutes of Health
iCODEHOP: a new interactive program for designing COnsensus-DEgenerate Hybrid Oligonucleotide Primers from multiply aligned protein sequences
R Boyce, P Chilana, TM Rose
Nucleic acids research 37 (suppl 2), W222-W228, 2009
Zorunlu olanlar: US National Institutes of Health
Accuracy of an automated knowledge base for identifying drug adverse reactions
EA Voss, RD Boyce, PB Ryan, J van der Lei, PR Rijnbeek, MJ Schuemie
Journal of Biomedical Informatics 66, 72-81, 2017
Zorunlu olanlar: US National Institutes of Health
Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available
M Samwald, H Xu, K Blagec, PE Empey, DC Malone, SM Ahmed, P Ryan, ...
PloS one 11 (10), e0164972, 2016
Zorunlu olanlar: US National Institutes of Health, Austrian Science Fund, European Commission
Multisite Evaluation of a Data Quality Tool for Patient-Level Clinical Data Sets
V Huser, FJ DeFalco, M Schuemie, PB Ryan, N Shang, M Velez, RW Park, ...
eGEMs 4 (1), 2016
Zorunlu olanlar: US National Institutes of Health
A review of the effectiveness of antidepressant medications for depressed nursing home residents
RD Boyce, JT Hanlon, JF Karp, J Kloke, A Saleh, SM Handler
Journal of the American Medical Directors Association 13 (4), 326-331, 2012
Zorunlu olanlar: US National Institutes of Health
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest
RD Boyce, PB Ryan, GN Norén, MJ Schuemie, C Reich, J Duke, ...
Drug Safety 37 (8), 557-567, 2014
Zorunlu olanlar: US National Institutes of Health
Fall risk-increasing drugs, polypharmacy, and falls among low-income community-dwelling older adults
K Ie, E Chou, RD Boyce, SM Albert
Innovation in aging 5 (1), igab001, 2021
Zorunlu olanlar: US National Institutes of Health
CODEHOP PCR and CODEHOP PCR Primer Design
JP Staheli, R Boyce, D Kovarik, TM Rose
Methods Mol. Bio 687, 57-73, 2011
Zorunlu olanlar: US National Institutes of Health
Age-related changes in antidepressant pharmacokinetics and potential drug-drug interactions: a comparison of evidence-based literature and package insert information
RD Boyce, SM Handler, JF Karp, JT Hanlon
The American journal of geriatric pharmacotherapy 10 (2), 139-150, 2012
Zorunlu olanlar: US National Institutes of Health
Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study
K Blagec, KM Romagnoli, RD Boyce, M Samwald
PeerJ 4, e1671, 2016
Zorunlu olanlar: US National Institutes of Health, Austrian Science Fund
Use of Telemedicine to Enhance Pharmacist Services in the Nursing Facility
SL Kane-Gill, JD Niznik, JA Kellum, CM Culley, RD Boyce, ZA Marcum, ...
The Consultant Pharmacist® 32 (2), 93-98, 2017
Zorunlu olanlar: US National Institutes of Health
Early prediction of Alzheimer's disease and related dementias using real‐world electronic health records
Q Li, X Yang, J Xu, Y Guo, X He, H Hu, T Lyu, D Marra, A Miller, G Smith, ...
Alzheimer's & Dementia 19 (8), 3506-3518, 2023
Zorunlu olanlar: US National Institutes of Health, Patient-Centered Outcomes Research …
Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements
KM Romagnoli, RD Boyce, PE Empey, S Adams, H Hochheiser
International Journal of Medical Informatics 86, 54-61, 2016
Zorunlu olanlar: US National Institutes of Health
Medication misadventures in the elderly: a year in review
ZA Marcum, SM Handler, R Boyce, W Gellad, JT Hanlon
The American journal of geriatric pharmacotherapy 8 (1), 77-83, 2010
Zorunlu olanlar: US National Institutes of Health
Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews
KM Romagnoli, SD Nelson, L Hines, P Empey, RD Boyce, H Hochheiser
BMC Medical Informatics and Decision Making 17 (1), 21, 2017
Zorunlu olanlar: US National Institutes of Health, US Department of Veterans Affairs
Implementing Genomic Clinical Decision Support for Drug‐Based Precision Medicine
RR Freimuth, CM Formea, JM Hoffman, E Matey, JF Peterson, RD Boyce
CPT: Pharmacometrics & Systems Pharmacology 6 (3), 153-155, 2017
Zorunlu olanlar: US National Institutes of Health
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir